View Older Stories View More Recent Stories
-
Monroe Capital Corporation Announces Public Offering of Notes and A- Rating from Egan-Jones Ratings Company
-
Monroe Capital Corporation Announces Public Offering of Notes and A- Rating from Egan-Jones Ratings Company
-
KemPharm to Present at Two Healthcare Investor Conferences During September 2018
-
Sarepta Therapeutics to Present at Two Upcoming Investor Conferences
-
ContraFect to Present at Two Upcoming Investor Conferences
-
Janney Montgomery Scott Downgrades Assertio Therapeutics (ASRT) to Neutral
-
Avid Bioservices to Present at Upcoming Investor Conferences
-
Concert Pharmaceuticals to Present at Upcoming Investor Conferences
-
Janney Montgomery Scott Downgrades Realty Income (O) to Neutral
-
Janney Montgomery Scott Downgrades Capital Product (CPLP) to Neutral
-
West Announces Participation in Upcoming September Investor Conferences
-
Gladstone Investment Corporation Announces Closing of Offering of 2,990,000 Shares of its 6.375% Series E Cumulative Term Preferred Stock for Gross Proceeds of Approximately $74.8 million
-
Gladstone Investment Corporation Announces Closing of Offering of 2,990,000 Shares of its 6.375% Series E Cumulative Term Preferred Stock for Gross Proceeds of Approximately $74.8 million
-
Janney Starts Nightstar Therapeutics (NITE) at Buy
-
Saratoga Investment Corp. Prices Public Offering of $35 Million 6.25% Notes Due 2025
-
Saratoga Investment Corp. Prices Public Offering of $35 Million 6.25% Notes Due 2025
-
Saratoga Investment Corp. Announces Offering of Notes Due 2025 and BBB Investment Grade Rating from Egan-Jones Ratings Company.
-
Saratoga Investment Corp. Announces Offering of Notes Due 2025 and BBB Investment Grade Rating from Egan-Jones Ratings Company.
-
Instant View: Trump takes Fed to task for rate hikes in Reuters interview
-
Exclusive: Trump demands Fed help on economy, complains about interest rate rises
-
Janney Montgomery Scott Upgrades America's Car-Mart (CRMT) to Buy
-
Emergent BioSolutions to Participate in Series of Near-Term Investor Conferences
-
Emergent BioSolutions to Participate in Series of Near-Term Investor Conferences
-
Janney Starts Azure Power Global Limited (AZRE) at Buy
-
Gladstone Investment Corporation Prices Series E Term Preferred Stock Offering
-
Gladstone Investment Corporation Prices Series E Term Preferred Stock Offering
-
Gladstone Investment Corporation Launches New Series E Term Preferred Stock Offering
-
Gladstone Investment Corporation Launches New Series E Term Preferred Stock Offering
-
Middlesex Water (MSEX) PT Raised to $47 at Janney Following Model Update
-
Consolidated Water (CWCO) PT Raised to $16 at Janney Montgomery Scott
-
Janney Downgrades Ampco-Pittsburgh (AP) to Neutral
-
NeoGenomics (NEO) Prices 9.8M Share Common Offering at $12.75/Sh
-
NeoGenomics Announces Pricing on Public Offering of Common Stock
-
NeoGenomics Announces Pricing on Public Offering of Common Stock
-
TriplePoint Venture Growth BDC Corp. Closes Public Offering and Expects to Close Concurrent Private Placement of Common Stock
-
American States Water (AWR) PT Raised to $51 at Janney Montgomery Scott
-
Cara Therapeutics Reports Second Quarter 2018 Financial Results
-
Cara Therapeutics Reports Second Quarter 2018 Financial Results
-
TriplePoint Venture Growth BDC (TPVG) Prices 6M Common Share Offering at $13.70/Sh
-
TriplePoint Venture Growth BDC Corp. Prices Public Offering and Concurrent Private Placement of Common Stock
-
SeaWorld Entertainment (SEAS) PT Raised to $31 at Janney Montgomery Scott
-
CAI International, Inc. Announces Pricing of Public Offering of Series B Preferred Stock
-
Janney Downgrades National Retail Properties (NNN) to Neutral Citing Valuation
-
NeoGenomics (NEO) Announces $125M Proposed Public Offering of Common Stock
-
NeoGenomics Announces Proposed Public Offering of Common Stock
-
NeoGenomics Announces Proposed Public Offering of Common Stock
-
CAI International, Inc. Announces Public Offering of Series B Preferred Stock
-
Fluidigm Corporation (FLDM) PT Raised to $9 at Janney Montgomery Scott
-
BioLife Solutions to Present and Exhibit at Fall Investor and Cell & Gene Therapy Conferences
-
Illumina (ILMN) PT Raised to $330 at Janney

